Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-015419
Filing Date
2022-10-26
Accepted
2022-10-26 16:59:54
Documents
8
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20221209xdef14a.htm DEF 14A 784477
2 GRAPHIC tmb-20221209xdef14a006.jpg GRAPHIC 3159
3 GRAPHIC tmb-20221209xdef14a008.jpg GRAPHIC 3584
4 GRAPHIC tmb-20221209xdef14a015.jpg GRAPHIC 193303
5 GRAPHIC tmb-20221209xdef14a012.jpg GRAPHIC 177507
6 GRAPHIC tmb-20221209xdef14a005.jpg GRAPHIC 5458
7 GRAPHIC tmb-20221209xdef14a013.jpg GRAPHIC 224623
8 GRAPHIC tmb-20221209xdef14a014.jpg GRAPHIC 233682
  Complete submission text file 0001558370-22-015419.txt   1945231
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-49908 | Film No.: 221333902
SIC: 2834 Pharmaceutical Preparations